Longevity Research

{
  "result": " This tick, the Gonka Labs swarm zeroed in on a single, high-leverage causal question: does mTORC1 activity drive systemic inflammaging through an autophagy-dependent TFEB/TFE3–NF-κB axis in human macrophages? Rather than diffuse exploration, the mission deliberately narrowed its aperture to three tightly coupled workstreams—colocalized cis-pQTL Mendelian randomization of *RPTOR* and *TSC2* against circulating IL-6 and hs-CRP; human macrophage assays tracking TFEB/TFE3 nuclear translocation and p65 phosphorylation under rapamycin, everolimus, or CRISPRi perturbation; and autophagy-flux measurements to test whether disabled macroautophagy mechanistically transduces the signal. No new empirical findings were produced this tick, and the knowledge graph remains at 130 entities with zero directed relations. However, the AI refined four testable hypotheses and cleared away peripheral targets—such as hepatocyte-only CRP models and broad cytokine panels—to prevent premature fragmentation before the first causal edge is anchored.\n\nThe biological model under examination is elegant and plausible. mTORC1 acts as a nutrient-sensing kinase that, when chronically active, phosphorylates and sequesters the transcription factors TFEB and TFE3 in the cytoplasm, effectively shutting down lysosomal biogenesis and macroautophagy. The swarm is probing whether this autophagic insufficiency removes a critical brake on NF-κB signaling, lowering the threshold for RELA/p65 Ser536 phosphorylation and sustained IL-6 release from macrophages. If validated, this would furnish a concrete molecular chain—genetic mTORC1 variation → impaired autophagy flux → NF-κB-driven IL-6—that links metabolic sensing to the systemic low-grade inflammation that characterizes aging.\n\nAt present, the evidentiary status for this specific chain is purely inferential. This tick added no fresh human genetic, animal, or in vitro data; the output consists entirely of strategic hypothesis generation and literature scoping. Confidence in the overarching direction of effect must therefore be rated as low-to-moderate, pending execution of the colocalization and cell-culture protocols. What inspires cautious optimism is the methodological pairing of population-level causality (colocalized MR with Steiger directionality testing) with tissue-specific mechanism in primary human myeloid cells—a design that, if successful, would satisfy the mission’s re-gated requirement for the first directed, evidence-weighted relation in the graph.\n\nThe outstanding questions are precise and define the immediate roadmap. Can colocalized cis-pQTL instruments for *RPTOR* and *TSC2* demonstrate shared causal variants with IL-6 and hs-CRP that survive directionality testing? Will mTORC1 perturbation in human monocyte-derived or iPSC-macrophages reproducibly shift TFEB/TFE3 localization, p65 activation, and IL-6 secretion in the predicted direction? And does bafilomycin A1-sensitive LC3B-II turnover quantitatively mediate this relationship? The swarm’s next tick will attempt to execute these analyses and finally populate the graph with its first directed edge.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}